| Anesthesia and Pain Management | Lifetime | 307 | IT 5 | 98.45 |
| Pain Mechanisms and Treatments | Lifetime | 342 | IT 10 | 98.39 |
| Pain Management and Opioid Use | Lifetime | 142 | IT 6 | 98.28 |
| Musculoskeletal pain and rehabilitation | Lifetime | 711 | IT 8 | 98.02 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | Lifetime | 521 | IT 10 | 95.83 |
| Pediatric Pain Management Techniques | Lifetime | 482 | IT 11 | 95.12 |
| Pain Management and Treatment | Lifetime | 369 | IT 11 | 93.67 |
| Opioid Use Disorder Treatment | Lifetime | 759 | IT 9 | 93.87 |
| Pain Management and Placebo Effect | Lifetime | 533 | IT 16 | 93.37 |
| Restless Legs Syndrome Research | Lifetime | 909 | IT 101 | 80.87 |
| Pain Management and Opioid Use | 2021-2025 | 2 | IT 1 | 99.56 |
| Pain Mechanisms and Treatments | 2021-2025 | 10 | IT 1 | 99.22 |
| Anesthesia and Pain Management | 2021-2025 | 20 | IT 1 | 99.07 |
| Musculoskeletal pain and rehabilitation | 2021-2025 | 39 | IT 2 | 99.29 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | 2021-2025 | 20 | IT 4 | 98.17 |
| Cardiac, Anesthesia and Surgical Outcomes | 2021-2025 | 141 | IT 16 | 98.21 |
| Spine and Intervertebral Disc Pathology | 2021-2025 | 191 | IT 7 | 97.35 |
| Pediatric Pain Management Techniques | 2021-2025 | 81 | IT 4 | 92.56 |
| Pain Management and Treatment | 2021-2025 | 68 | IT 1 | 94.05 |
| Botulinum Toxin and Related Neurological Disorders | 2021-2025 | 230 | IT 42 | 91.97 |
| Intestinal and Peritoneal Adhesions | 2021-2025 | 60 | IT 4 | 87.79 |
| Gastroesophageal reflux and treatments | 2021-2025 | 266 | IT 31 | 91.07 |
| Pain Management and Placebo Effect | 2021-2025 | 103 | IT 4 | 90.67 |
| Pharmacological Receptor Mechanisms and Effects | 2021-2025 | 69 | IT 9 | 86.35 |
| Myofascial pain diagnosis and treatment | 2021-2025 | 150 | IT 20 | 87.05 |
| Inflammatory mediators and NSAID effects | 2021-2025 | 159 | IT 12 | 84.91 |
| Opioid Use Disorder Treatment | 2021-2025 | 527 | IT 2 | 89.82 |
| Gastrointestinal motility and disorders | 2021-2025 | 445 | IT 30 | 86.62 |
| Peripheral Nerve Disorders | 2021-2025 | 279 | IT 16 | 81.06 |
| Peripheral Neuropathies and Disorders | 2021-2025 | 668 | IT 85 | 84.43 |
| Forensic Toxicology and Drug Analysis | 2021-2025 | 299 | IT 35 | 83.65 |
| Anesthesia and Sedative Agents | 2021-2025 | 656 | IT 23 | 80.28 |
| Acupuncture Treatment Research Studies | 2021-2025 | 405 | IT 1 | 80.50 |
| Trigeminal Neuralgia and Treatments | 2021-2025 | 368 | IT 71 | 78.08 |
| Veterinary Pharmacology and Anesthesia | 2021-2025 | 490 | IT 47 | 64.07 |
| Neurological and metabolic disorders | 2021-2025 | 333 | IT 19 | 63.16 |
| Nausea and vomiting management | 2021-2025 | 983 | IT 35 | 57.16 |
| Potassium and Related Disorders | 2021-2025 | 897 | IT 66 | 55.16 |
| Therapeutic Uses of Natural Elements | 2021-2025 | 634 | IT 81 | 38.75 |
| Magnesium in Health and Disease | 2021-2025 | 800 | IT 40 | 30.18 |
| Sympathectomy and Hyperhidrosis Treatments | 2021-2025 | 800 | IT 105 | 31.46 |
| Foreign Body Medical Cases | 2021-2025 | 677 | IT 66 | 22.88 |